Sign in to view content

Six Monthly Intravitreal Aflibercept to Improve Macular Perfusion in Diabetic Retinopathy Without Macular Edema

Yoon Jeon Kim, MD

Video
Published 2023

Related

VERONA: End-of-Study Results From a Phase 2 Trial of EYP-1901 (Vorolanib Intravitreal Insert) vs Aflibercept for Diabetic Macular Edema
Yasha S Modi, MD
Updates from the Field
2025
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Annual Meeting Talks
2022
Study of Comparative Treatments for REtinal Vein Occlusion 2 (SCORE2): Primary Results
Ingrid U. Scott, MD, MPH
Updates from the Field
2017

Category: Diabetic Retinopathy

See more